1. Home
  2. AMPG vs ANL Comparison

AMPG vs ANL Comparison

Compare AMPG & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$4.02

Market Cap

71.1M

ML Signal

HOLD

Logo Adlai Nortye Ltd.

ANL

Adlai Nortye Ltd.

HOLD

Current Price

$2.01

Market Cap

62.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPG
ANL
Founded
2002
2004
Country
United States
Cayman Islands
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
71.1M
62.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
AMPG
ANL
Price
$4.02
$2.01
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
655.8K
1.3M
Earning Date
11-14-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,571,945.00
N/A
Revenue This Year
$168.18
N/A
Revenue Next Year
$100.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
93.47
N/A
52 Week Low
$1.21
$0.88
52 Week High
$4.89
$2.75

Technical Indicators

Market Signals
Indicator
AMPG
ANL
Relative Strength Index (RSI) 64.51 69.41
Support Level $3.36 $1.63
Resistance Level $3.90 $1.93
Average True Range (ATR) 0.35 0.15
MACD 0.04 0.04
Stochastic Oscillator 85.22 93.16

Price Performance

Historical Comparison
AMPG
ANL

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About ANL Adlai Nortye Ltd.

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.

Share on Social Networks: